Are you over 18 and want to see adult content?
More Annotations
![النقيب للمعلوماتية | التكنولوجيا هي طريقة الحياة الجديدة](https://www.archivebay.com/archive/920cd265-105e-445d-8aa5-623e07d01ef9.png)
النقيب للمعلوماتية | التكنولوجيا هي طريقة الحياة الجديدة
Are you over 18 and want to see adult content?
![ZERO HORA SERGIPE – Portal de Notícias, Negócios & Oportunidades!](https://www.archivebay.com/archive/063156d3-513f-4261-abbb-688084ce7ff9.png)
ZERO HORA SERGIPE – Portal de Notícias, Negócios & Oportunidades!
Are you over 18 and want to see adult content?
![Home | United States | New Mexico Genealogical Society](https://www.archivebay.com/archive/b9cded0c-6dc5-4116-a2eb-80de4604b673.png)
Home | United States | New Mexico Genealogical Society
Are you over 18 and want to see adult content?
![Peliculas Online | Ver Peliculas Gratis](https://www.archivebay.com/archive/2a3dfefa-3d45-4283-a0b9-b93797158878.png)
Peliculas Online | Ver Peliculas Gratis
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of denverboyscouts.org](https://www.archivebay.com/archive5/images/cc8dba1e-67ae-41d0-985a-274394b131c8.png)
A complete backup of denverboyscouts.org
Are you over 18 and want to see adult content?
![A complete backup of jamesbondmm.co.uk](https://www.archivebay.com/archive5/images/6b264f50-2a6c-4691-8a8d-57f374d8a7e0.png)
A complete backup of jamesbondmm.co.uk
Are you over 18 and want to see adult content?
![A complete backup of nationalparkhaus-wattenmeer.de](https://www.archivebay.com/archive5/images/61f25a66-6216-4435-8719-2930d97477eb.png)
A complete backup of nationalparkhaus-wattenmeer.de
Are you over 18 and want to see adult content?
![A complete backup of print-gakufu.com](https://www.archivebay.com/archive5/images/5cf432f2-66f0-4b3a-918a-52de04ff2c28.png)
A complete backup of print-gakufu.com
Are you over 18 and want to see adult content?
![A complete backup of a-health-supplement.eu](https://www.archivebay.com/archive5/images/036267ca-7741-43d5-8066-6e81790485d3.png)
A complete backup of a-health-supplement.eu
Are you over 18 and want to see adult content?
Text
percent of COPD
PROTEIN LINKED TO FIBROSIS WILL BE FOCUS OF START-UP'S Protein Linked to Fibrosis Progression Will Be Focus of Start-up’s Drive for Anti-fibrotic Therapy. August 31, 2017. August 31, 2017. by Alice Melão. In Idiopathic Pulmonary Fibrosis, News. 0. ( 0) Researchers in Singapore have found that inhibiting a protein called interleukin-11, or IL-11, can block fibrosis progression in mice.Enleofen
A LARGE BELLY MAY BE RELATED TO HIGHER INCIDENCE OF COPD A Large Belly May Be Related To Higher Incidence Of COPD. In COPD, News. Excessive belly fat is a risk factor for chronic obstructive pulmonary disease, according to a study led by a group of German and American researchers published by the Canadian Medical Association Journal. For ten years (1995-2005), researchers observed 113,279people in
LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary 7 FAMOUS PEOPLE WHO LOST THEIR BATTLE WITH PULMONARY Sheila Matthews Allen Sheila Matthews Allen was a Hollywood actress famous for roles in the films Poseidon Adventure and Towering Inferno and TV shows like Lost in Space and The Waltons.Allen passed away in November 2013 after a prolonged battle with pulmonary fibrosis. AIRWAY RESISTANCE MEASUREMENTS SHOWN TO HELP EFFECTIVELY Airway resistance (RAW) and specific airway conductance (sGAW) are measures that reflect airway function. However, little is known of the variability of these measures between different lung diseases. In a recent study published in the journal Respiratory Research, a team of researchers from the Department of Clinical and Experimental Medicine, University of Leuven in Belgium found that RAW CONSIDERING LUNG TRANSPLANTATION: THE PROS & CONS Considering Lung Transplantation: The Pros & Cons. February 20, 2018. by Charlene Marshall. In Social Clips. 5. ( 1) When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them with new ones, most people would think that opting for a double lung transplant would be a no-brainer. 6 PULMONARY FIBROSIS COMPLICATIONS According to the Mayo Clinic, though no current cure for pulmonary fibrosis exists, medications and other treatment options can help improve a patient’s quality of life. As the disease evolves, several complications may arise. Here is a list of six possible pulmonary fibrosis complications: 1. IPF PATIENTS' LONG-TERM LUNG FUNCTION IMPROVES WITH OFEV IPF is a progressive lung disease with a median survival rate of only three years after diagnosis. The Phase 2 TOMORROW trial ( NCT00514683) evaluated Ofev ’s safety and effectiveness in two periods. Period 1 covered 52 weeks. The 428 patients in the randomized, placebo-controlled study received one of four doses of Ofev. HOW PETS BENEFIT PULMONARY FIBROSIS PATIENTS Especially if that illness is coupled with depression or chronic pain, mobilization is usually encouraged by physicians and having to get up to let the dog outside, or feed the cat, is an encouraging reason to get up in the morning. Regardless of how you are feeling, pets need us and they reciprocate that need by showing us love and companionship. COPD STUDY LINKS PATIENTS' BRONCHIECTASIS TO FUNGUS ANTIBODIES The study involved 350 people — 300 with COPD and 50 controls who were former smokers. Significantly more COPD patients had bronchiectasis — 33 percent — than the controls — 10 percent. Researchers measured the levels of all participants’ seven antibodies against A fum. They found significantly higher levels in 18percent of COPD
PROTEIN LINKED TO FIBROSIS WILL BE FOCUS OF START-UP'S Protein Linked to Fibrosis Progression Will Be Focus of Start-up’s Drive for Anti-fibrotic Therapy. August 31, 2017. August 31, 2017. by Alice Melão. In Idiopathic Pulmonary Fibrosis, News. 0. ( 0) Researchers in Singapore have found that inhibiting a protein called interleukin-11, or IL-11, can block fibrosis progression in mice.Enleofen
A LARGE BELLY MAY BE RELATED TO HIGHER INCIDENCE OF COPD A Large Belly May Be Related To Higher Incidence Of COPD. In COPD, News. Excessive belly fat is a risk factor for chronic obstructive pulmonary disease, according to a study led by a group of German and American researchers published by the Canadian Medical Association Journal. For ten years (1995-2005), researchers observed 113,279people in
LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary PULMONARY FIBROSIS SYMPTOMS: ACHING JOINTS AND MUSCLES Pulmonary fibrosis is a chronic lung disease where tissue in the lungs becomes scarred and thickens. This leads to common symptoms such as a persistent cough, shortness of breath, weight loss, fatigue, and digital clubbing. MORE: 6 Famous People Who Lost Their Battle With Pulmonary Fibrosis. Many pulmonary fibrosis patients also suffer from aching joints and muscles. PULMONARY FIBROSIS SYMPTOMS: FATIGUE There are many symptoms associated with pulmonary fibrosis (PF), but fatigue is often cited as one of the most difficult to deal with by those living with the disease.. MORE: 4 Breathing Mistakes You’re Probably Making. Fatigue in pulmonary fibrosis goes much further than simply being tired and often can’t be remedied by a good night’s sleep. . Fatigue can be so debilitating that it 6 PULMONARY FIBROSIS COMPLICATIONS According to the Mayo Clinic, though no current cure for pulmonary fibrosis exists, medications and other treatment options can help improve a patient’s quality of life. As the disease evolves, several complications may arise. Here is a list of six possible pulmonary fibrosis complications: 1. MOST RELIABLE IPF THERAPIES ARE ESBRIET, OFEV, COMPARISON The first two approved therapies for idiopathic pulmonary fibrosis (IPF), Genentech’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib), are still the most reliable treatments among several approved and experimental therapies, according to a comparison study featured in the journal Pharmacometrics & Systems Pharmacology.. Since the U.S. FDA’s approval of these two IPF 10 LUNG TRANSPLANT FACTS Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. PROTEIN LINKED TO FIBROSIS WILL BE FOCUS OF START-UP'S Researchers in Singapore have found that inhibiting a protein called interleukin-11, or IL-11, can block fibrosis progression in mice. Enleofen Bio, a recently founded biotechnology start-up company, will try to move this finding into the clinic by working to develop new therapeutics targeting IL-11 for the treatment of fibrotic diseases, such as cardiac and pulmonary fibrosis. GALECTO'S IPF DRUG CANDIDATE TD139 SHOWS PROMISE IN Galecto Biotech has completed a Phase 1b/2a clinical trial that indicated its inhaled therapy candidate TD139 shows promise in treating idiopathic pulmonary fibrosis (IPF) patients.. TD139 is an inhibitor of galectin-3, a protein known to play a key role in fibrosis in several organs, including the lungs. Previous studies have shown that inhibiting galectin-3 reduced or even prevented fibrosis RESPIRATORY INFECTION LINKED TO INCREASED RISK OF HEART ATTACK Respiratory Infections Linked to Increased Risk of Heart Attack. In Chronic Bronchitis, News, Pneumonia. New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a heart attack, is 17 times higher in the seven days following a respiratory tractinfection.
LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary COPD CARE AT HOME RATHER THAN HOSPITAL BOOSTS PATIENT Moving chronic obstructive pulmonary disease (COPD) patients from hospitals to their homes could improve the sustainability of Canada’s health system while improving individual outcomes, says the Canadian Foundation for Healthcare Improvement (CFHI).. Data from health systems participating in the INSPIRED study conclude that offering Canadian COPD patients the right support 7 FAMOUS PEOPLE WHO LOST THEIR BATTLE WITH PULMONARY Sheila Matthews Allen Sheila Matthews Allen was a Hollywood actress famous for roles in the films Poseidon Adventure and Towering Inferno and TV shows like Lost in Space and The Waltons.Allen passed away in November 2013 after a prolonged battle with pulmonary fibrosis. AIRWAY RESISTANCE MEASUREMENTS SHOWN TO HELP EFFECTIVELY Airway resistance (RAW) and specific airway conductance (sGAW) are measures that reflect airway function. However, little is known of the variability of these measures between different lung diseases. In a recent study published in the journal Respiratory Research, a team of researchers from the Department of Clinical and Experimental Medicine, University of Leuven in Belgium found that RAW CONSIDERING LUNG TRANSPLANTATION: THE PROS & CONS Considering Lung Transplantation: The Pros & Cons. February 20, 2018. by Charlene Marshall. In Social Clips. 5. ( 1) When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them with new ones, most people would think that opting for a double lung transplant would be a no-brainer. 6 PULMONARY FIBROSIS COMPLICATIONS According to the Mayo Clinic, though no current cure for pulmonary fibrosis exists, medications and other treatment options can help improve a patient’s quality of life. As the disease evolves, several complications may arise. Here is a list of six possible pulmonary fibrosis complications: 1. IPF PATIENTS' LONG-TERM LUNG FUNCTION IMPROVES WITH OFEV IPF is a progressive lung disease with a median survival rate of only three years after diagnosis. The Phase 2 TOMORROW trial ( NCT00514683) evaluated Ofev ’s safety and effectiveness in two periods. Period 1 covered 52 weeks. The 428 patients in the randomized, placebo-controlled study received one of four doses of Ofev. HOW PETS BENEFIT PULMONARY FIBROSIS PATIENTS Especially if that illness is coupled with depression or chronic pain, mobilization is usually encouraged by physicians and having to get up to let the dog outside, or feed the cat, is an encouraging reason to get up in the morning. Regardless of how you are feeling, pets need us and they reciprocate that need by showing us love and companionship. COPD STUDY LINKS PATIENTS' BRONCHIECTASIS TO FUNGUS ANTIBODIES The study involved 350 people — 300 with COPD and 50 controls who were former smokers. Significantly more COPD patients had bronchiectasis — 33 percent — than the controls — 10 percent. Researchers measured the levels of all participants’ seven antibodies against A fum. They found significantly higher levels in 18percent of COPD
PROTEIN LINKED TO FIBROSIS WILL BE FOCUS OF START-UP'S Protein Linked to Fibrosis Progression Will Be Focus of Start-up’s Drive for Anti-fibrotic Therapy. August 31, 2017. August 31, 2017. by Alice Melão. In Idiopathic Pulmonary Fibrosis, News. 0. ( 0) Researchers in Singapore have found that inhibiting a protein called interleukin-11, or IL-11, can block fibrosis progression in mice.Enleofen
A LARGE BELLY MAY BE RELATED TO HIGHER INCIDENCE OF COPD A Large Belly May Be Related To Higher Incidence Of COPD. In COPD, News. Excessive belly fat is a risk factor for chronic obstructive pulmonary disease, according to a study led by a group of German and American researchers published by the Canadian Medical Association Journal. For ten years (1995-2005), researchers observed 113,279people in
LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary 7 FAMOUS PEOPLE WHO LOST THEIR BATTLE WITH PULMONARY Sheila Matthews Allen Sheila Matthews Allen was a Hollywood actress famous for roles in the films Poseidon Adventure and Towering Inferno and TV shows like Lost in Space and The Waltons.Allen passed away in November 2013 after a prolonged battle with pulmonary fibrosis. AIRWAY RESISTANCE MEASUREMENTS SHOWN TO HELP EFFECTIVELY Airway resistance (RAW) and specific airway conductance (sGAW) are measures that reflect airway function. However, little is known of the variability of these measures between different lung diseases. In a recent study published in the journal Respiratory Research, a team of researchers from the Department of Clinical and Experimental Medicine, University of Leuven in Belgium found that RAW CONSIDERING LUNG TRANSPLANTATION: THE PROS & CONS Considering Lung Transplantation: The Pros & Cons. February 20, 2018. by Charlene Marshall. In Social Clips. 5. ( 1) When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them with new ones, most people would think that opting for a double lung transplant would be a no-brainer. 6 PULMONARY FIBROSIS COMPLICATIONS According to the Mayo Clinic, though no current cure for pulmonary fibrosis exists, medications and other treatment options can help improve a patient’s quality of life. As the disease evolves, several complications may arise. Here is a list of six possible pulmonary fibrosis complications: 1. IPF PATIENTS' LONG-TERM LUNG FUNCTION IMPROVES WITH OFEV IPF is a progressive lung disease with a median survival rate of only three years after diagnosis. The Phase 2 TOMORROW trial ( NCT00514683) evaluated Ofev ’s safety and effectiveness in two periods. Period 1 covered 52 weeks. The 428 patients in the randomized, placebo-controlled study received one of four doses of Ofev. HOW PETS BENEFIT PULMONARY FIBROSIS PATIENTS Especially if that illness is coupled with depression or chronic pain, mobilization is usually encouraged by physicians and having to get up to let the dog outside, or feed the cat, is an encouraging reason to get up in the morning. Regardless of how you are feeling, pets need us and they reciprocate that need by showing us love and companionship. COPD STUDY LINKS PATIENTS' BRONCHIECTASIS TO FUNGUS ANTIBODIES The study involved 350 people — 300 with COPD and 50 controls who were former smokers. Significantly more COPD patients had bronchiectasis — 33 percent — than the controls — 10 percent. Researchers measured the levels of all participants’ seven antibodies against A fum. They found significantly higher levels in 18percent of COPD
PROTEIN LINKED TO FIBROSIS WILL BE FOCUS OF START-UP'S Protein Linked to Fibrosis Progression Will Be Focus of Start-up’s Drive for Anti-fibrotic Therapy. August 31, 2017. August 31, 2017. by Alice Melão. In Idiopathic Pulmonary Fibrosis, News. 0. ( 0) Researchers in Singapore have found that inhibiting a protein called interleukin-11, or IL-11, can block fibrosis progression in mice.Enleofen
A LARGE BELLY MAY BE RELATED TO HIGHER INCIDENCE OF COPD A Large Belly May Be Related To Higher Incidence Of COPD. In COPD, News. Excessive belly fat is a risk factor for chronic obstructive pulmonary disease, according to a study led by a group of German and American researchers published by the Canadian Medical Association Journal. For ten years (1995-2005), researchers observed 113,279people in
LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary PULMONARY FIBROSIS SYMPTOMS: ACHING JOINTS AND MUSCLES Pulmonary fibrosis is a chronic lung disease where tissue in the lungs becomes scarred and thickens. This leads to common symptoms such as a persistent cough, shortness of breath, weight loss, fatigue, and digital clubbing. MORE: 6 Famous People Who Lost Their Battle With Pulmonary Fibrosis. Many pulmonary fibrosis patients also suffer from aching joints and muscles. PULMONARY FIBROSIS SYMPTOMS: FATIGUE There are many symptoms associated with pulmonary fibrosis (PF), but fatigue is often cited as one of the most difficult to deal with by those living with the disease.. MORE: 4 Breathing Mistakes You’re Probably Making. Fatigue in pulmonary fibrosis goes much further than simply being tired and often can’t be remedied by a good night’s sleep. . Fatigue can be so debilitating that it 6 PULMONARY FIBROSIS COMPLICATIONS According to the Mayo Clinic, though no current cure for pulmonary fibrosis exists, medications and other treatment options can help improve a patient’s quality of life. As the disease evolves, several complications may arise. Here is a list of six possible pulmonary fibrosis complications: 1. MOST RELIABLE IPF THERAPIES ARE ESBRIET, OFEV, COMPARISON The first two approved therapies for idiopathic pulmonary fibrosis (IPF), Genentech’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib), are still the most reliable treatments among several approved and experimental therapies, according to a comparison study featured in the journal Pharmacometrics & Systems Pharmacology.. Since the U.S. FDA’s approval of these two IPF 10 LUNG TRANSPLANT FACTS Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. PROTEIN LINKED TO FIBROSIS WILL BE FOCUS OF START-UP'S Researchers in Singapore have found that inhibiting a protein called interleukin-11, or IL-11, can block fibrosis progression in mice. Enleofen Bio, a recently founded biotechnology start-up company, will try to move this finding into the clinic by working to develop new therapeutics targeting IL-11 for the treatment of fibrotic diseases, such as cardiac and pulmonary fibrosis. GALECTO'S IPF DRUG CANDIDATE TD139 SHOWS PROMISE IN Galecto Biotech has completed a Phase 1b/2a clinical trial that indicated its inhaled therapy candidate TD139 shows promise in treating idiopathic pulmonary fibrosis (IPF) patients.. TD139 is an inhibitor of galectin-3, a protein known to play a key role in fibrosis in several organs, including the lungs. Previous studies have shown that inhibiting galectin-3 reduced or even prevented fibrosis RESPIRATORY INFECTION LINKED TO INCREASED RISK OF HEART ATTACK Respiratory Infections Linked to Increased Risk of Heart Attack. In Chronic Bronchitis, News, Pneumonia. New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a heart attack, is 17 times higher in the seven days following a respiratory tractinfection.
LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary COPD CARE AT HOME RATHER THAN HOSPITAL BOOSTS PATIENT Moving chronic obstructive pulmonary disease (COPD) patients from hospitals to their homes could improve the sustainability of Canada’s health system while improving individual outcomes, says the Canadian Foundation for Healthcare Improvement (CFHI).. Data from health systems participating in the INSPIRED study conclude that offering Canadian COPD patients the right support 7 AIRWAY CLEARANCE TECHNIQUES According to the Cystic Fibrosis Foundation, there are seven major airway clearance techniques (ACTs) for patients with lung disease.Airway clearance is needed to help clear away mucus from the lungs to help prevent infections and to improve lung function. Children will need an adult to assist with ACTs, and different pulmonary fibrosis (PF) patients will prefer different methods ofairway
COPD AND BRONCHIECTASIS: SIMILARITIES AND DIFFERENCESSEE MORE ONLUNGDISEASENEWS.COM
AIRWAY RESISTANCE MEASUREMENTS SHOWN TO HELP EFFECTIVELY Airway resistance (RAW) and specific airway conductance (sGAW) are measures that reflect airway function. However, little is known of the variability of these measures between different lung diseases. In a recent study published in the journal Respiratory Research, a team of researchers from the Department of Clinical and Experimental Medicine, University of Leuven in Belgium found that RAW CONSIDERING LUNG TRANSPLANTATION: THE PROS & CONS Considering Lung Transplantation: The Pros & Cons. February 20, 2018. by Charlene Marshall. In Social Clips. 5. ( 1) When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them with new ones, most people would think that opting for a double lung transplant would be a no-brainer. 7 FAMOUS PEOPLE WHO LOST THEIR BATTLE WITH PULMONARY Sheila Matthews Allen Sheila Matthews Allen was a Hollywood actress famous for roles in the films Poseidon Adventure and Towering Inferno and TV shows like Lost in Space and The Waltons.Allen passed away in November 2013 after a prolonged battle with pulmonary fibrosis. IPF PATIENTS' LONG-TERM LUNG FUNCTION IMPROVES WITH OFEV IPF is a progressive lung disease with a median survival rate of only three years after diagnosis. The Phase 2 TOMORROW trial ( NCT00514683) evaluated Ofev ’s safety and effectiveness in two periods. Period 1 covered 52 weeks. The 428 patients in the randomized, placebo-controlled study received one of four doses of Ofev. RESPIRATORY INFECTION LINKED TO INCREASED RISK OF HEART ATTACK Respiratory Infections Linked to Increased Risk of Heart Attack. In Chronic Bronchitis, News, Pneumonia. New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a heart attack, is 17 times higher in the seven days following a respiratory tractinfection.
HOW PETS BENEFIT PULMONARY FIBROSIS PATIENTS Especially if that illness is coupled with depression or chronic pain, mobilization is usually encouraged by physicians and having to get up to let the dog outside, or feed the cat, is an encouraging reason to get up in the morning. Regardless of how you are feeling, pets need us and they reciprocate that need by showing us love and companionship. LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary COMING SOON: SMARTWATCH THAT MONITORS SPO2 AND VITAL SIGNS Wearable devices have been trending in the tech market, boasting hi-tech features that allow real-time fitness and body response tracking and syncing with one’s smartphone. Biomedical companies, such as Aseptika Limited, specialize in developing and marketing an integrated suite of self-monitoring devices and services under their Activ8rlives brand, with a focus on respiratory conditions. 7 AIRWAY CLEARANCE TECHNIQUES According to the Cystic Fibrosis Foundation, there are seven major airway clearance techniques (ACTs) for patients with lung disease.Airway clearance is needed to help clear away mucus from the lungs to help prevent infections and to improve lung function. Children will need an adult to assist with ACTs, and different pulmonary fibrosis (PF) patients will prefer different methods ofairway
COPD AND BRONCHIECTASIS: SIMILARITIES AND DIFFERENCESSEE MORE ONLUNGDISEASENEWS.COM
AIRWAY RESISTANCE MEASUREMENTS SHOWN TO HELP EFFECTIVELY Airway resistance (RAW) and specific airway conductance (sGAW) are measures that reflect airway function. However, little is known of the variability of these measures between different lung diseases. In a recent study published in the journal Respiratory Research, a team of researchers from the Department of Clinical and Experimental Medicine, University of Leuven in Belgium found that RAW CONSIDERING LUNG TRANSPLANTATION: THE PROS & CONS Considering Lung Transplantation: The Pros & Cons. February 20, 2018. by Charlene Marshall. In Social Clips. 5. ( 1) When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them with new ones, most people would think that opting for a double lung transplant would be a no-brainer. 7 FAMOUS PEOPLE WHO LOST THEIR BATTLE WITH PULMONARY Sheila Matthews Allen Sheila Matthews Allen was a Hollywood actress famous for roles in the films Poseidon Adventure and Towering Inferno and TV shows like Lost in Space and The Waltons.Allen passed away in November 2013 after a prolonged battle with pulmonary fibrosis. IPF PATIENTS' LONG-TERM LUNG FUNCTION IMPROVES WITH OFEV IPF is a progressive lung disease with a median survival rate of only three years after diagnosis. The Phase 2 TOMORROW trial ( NCT00514683) evaluated Ofev ’s safety and effectiveness in two periods. Period 1 covered 52 weeks. The 428 patients in the randomized, placebo-controlled study received one of four doses of Ofev. RESPIRATORY INFECTION LINKED TO INCREASED RISK OF HEART ATTACK Respiratory Infections Linked to Increased Risk of Heart Attack. In Chronic Bronchitis, News, Pneumonia. New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a heart attack, is 17 times higher in the seven days following a respiratory tractinfection.
HOW PETS BENEFIT PULMONARY FIBROSIS PATIENTS Especially if that illness is coupled with depression or chronic pain, mobilization is usually encouraged by physicians and having to get up to let the dog outside, or feed the cat, is an encouraging reason to get up in the morning. Regardless of how you are feeling, pets need us and they reciprocate that need by showing us love and companionship. LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary COMING SOON: SMARTWATCH THAT MONITORS SPO2 AND VITAL SIGNS Wearable devices have been trending in the tech market, boasting hi-tech features that allow real-time fitness and body response tracking and syncing with one’s smartphone. Biomedical companies, such as Aseptika Limited, specialize in developing and marketing an integrated suite of self-monitoring devices and services under their Activ8rlives brand, with a focus on respiratory conditions.LUNG DISEASE NEWS
Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. 10 LUNG TRANSPLANT FACTS Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. 7 FAMOUS PEOPLE WHO LOST THEIR BATTLE WITH PULMONARY Sheila Matthews Allen Sheila Matthews Allen was a Hollywood actress famous for roles in the films Poseidon Adventure and Towering Inferno and TV shows like Lost in Space and The Waltons.Allen passed away in November 2013 after a prolonged battle with pulmonary fibrosis. 6 PULMONARY FIBROSIS COMPLICATIONS According to the Mayo Clinic, though no current cure for pulmonary fibrosis exists, medications and other treatment options can help improve a patient’s quality of life. As the disease evolves, several complications may arise. Here is a list of six possible pulmonary fibrosis complications: 1. RESPIRATORY INFECTION LINKED TO INCREASED RISK OF HEART ATTACK New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a heart attack, is 17 times higher in the seven days following a respiratory tract infection.. The study, “ Triggering of acute myocardial infarction by respiratory infection,” was published in the Internal Medicine Journal. HOW PETS BENEFIT PULMONARY FIBROSIS PATIENTS Especially if that illness is coupled with depression or chronic pain, mobilization is usually encouraged by physicians and having to get up to let the dog outside, or feed the cat, is an encouraging reason to get up in the morning. Regardless of how you are feeling, pets need us and they reciprocate that need by showing us love and companionship. COMING SOON: SMARTWATCH THAT MONITORS SPO2 AND VITAL SIGNS Wearable devices have been trending in the tech market, boasting hi-tech features that allow real-time fitness and body response tracking and syncing with one’s smartphone. Biomedical companies, such as Aseptika Limited, specialize in developing and marketing an integrated suite of self-monitoring devices and services under their Activ8rlives brand, with a focus on respiratory conditions. POTENTIAL IPF THERAPY SEEN IN INHALED THYROID HORMONE IN A study led by researchers at Yale School of Medicine showed that an inhalation treatment based on thyroid hormone can significantly reverse lung scarring (fibrosis) in mice models of pulmonary fibrosis and in cultured human airway cells.. The study demonstrated that thyroid hormone may represent a potential therapy for diseases involving lung fibrosis, such as idiopathic pulmonary fibrosis (IPF). ADULTS BORN PREMATURE HAVE LUNG LIMITATIONS SIMILAR TO According to a recent study published in the Annals of the American Thoracic Society, adults born very or extremely preterm have respiratory limitations to exercise similar to patients with chronic obstructive pulmonary disease, similar to healthy elderly or casual smokers by the time they reach their early 20s.. The study, led by Andrew T. Lovering, a professor of human physiology at the PF PROGRESSION CAN BE SLOWED BY PRM, A TRADITIONAL CHINESE Pulmonary rehabilitation mixture (PRM), an herbal-based formula used for decades in Chinese traditional medicine, has therapeutic potential against pulmonary fibrosis (PF) progression by targeting several molecular factors known to be involved in fibrotic processes, concludes a new study.LUNG DISEASE NEWS
Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. 7 AIRWAY CLEARANCE TECHNIQUES According to the Cystic Fibrosis Foundation, there are seven major airway clearance techniques (ACTs) for patients with lung disease.Airway clearance is needed to help clear away mucus from the lungs to help prevent infections and to improve lung function. Children will need an adult to assist with ACTs, and different pulmonary fibrosis (PF) patients will prefer different methods ofairway
AIRWAY RESISTANCE MEASUREMENTS SHOWN TO HELP EFFECTIVELY Airway resistance (RAW) and specific airway conductance (sGAW) are measures that reflect airway function. However, little is known of the variability of these measures between different lung diseases. In a recent study published in the journal Respiratory Research, a team of researchers from the Department of Clinical and Experimental Medicine, University of Leuven in Belgium found that RAW CONSIDERING LUNG TRANSPLANTATION: THE PROS & CONS Considering Lung Transplantation: The Pros & Cons. February 20, 2018. by Charlene Marshall. In Social Clips. 5. ( 1) When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them with new ones, most people would think that opting for a double lung transplant would be a no-brainer. IPF TREATMENT ESBRIET HELPS REDUCE COUGH, 12-WEEK EUROPEAN Treatment with Esbriet (pirfenidone) significantly reduced cough by 34 percent in patients with idiopathic pulmonary fibrosis (IPF), along with cough severity, a new 12-week study shows. The study, “ Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis ” appeared in the European Respiratory journal.It marks the first time a clinical trial shows a significant IPF PATIENTS' LONG-TERM LUNG FUNCTION IMPROVES WITH OFEV IPF is a progressive lung disease with a median survival rate of only three years after diagnosis. The Phase 2 TOMORROW trial ( NCT00514683) evaluated Ofev ’s safety and effectiveness in two periods. Period 1 covered 52 weeks. The 428 patients in the randomized, placebo-controlled study received one of four doses of Ofev. MOST RELIABLE IPF THERAPIES ARE ESBRIET, OFEV, COMPARISON The first two approved therapies for idiopathic pulmonary fibrosis (IPF), Genentech’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib), are still the most reliable treatments among several approved and experimental therapies, according to a comparison study featured in the journal Pharmacometrics & Systems Pharmacology.. Since the U.S. FDA’s approval of these two IPF COPD AND BRONCHIECTASIS: SIMILARITIES AND DIFFERENCESSEE MORE ONLUNGDISEASENEWS.COM
LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary COMING SOON: SMARTWATCH THAT MONITORS SPO2 AND VITAL SIGNS Wearable devices have been trending in the tech market, boasting hi-tech features that allow real-time fitness and body response tracking and syncing with one’s smartphone. Biomedical companies, such as Aseptika Limited, specialize in developing and marketing an integrated suite of self-monitoring devices and services under their Activ8rlives brand, with a focus on respiratory conditions.LUNG DISEASE NEWS
Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. 7 AIRWAY CLEARANCE TECHNIQUES According to the Cystic Fibrosis Foundation, there are seven major airway clearance techniques (ACTs) for patients with lung disease.Airway clearance is needed to help clear away mucus from the lungs to help prevent infections and to improve lung function. Children will need an adult to assist with ACTs, and different pulmonary fibrosis (PF) patients will prefer different methods ofairway
AIRWAY RESISTANCE MEASUREMENTS SHOWN TO HELP EFFECTIVELY Airway resistance (RAW) and specific airway conductance (sGAW) are measures that reflect airway function. However, little is known of the variability of these measures between different lung diseases. In a recent study published in the journal Respiratory Research, a team of researchers from the Department of Clinical and Experimental Medicine, University of Leuven in Belgium found that RAW CONSIDERING LUNG TRANSPLANTATION: THE PROS & CONS Considering Lung Transplantation: The Pros & Cons. February 20, 2018. by Charlene Marshall. In Social Clips. 5. ( 1) When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them with new ones, most people would think that opting for a double lung transplant would be a no-brainer. IPF TREATMENT ESBRIET HELPS REDUCE COUGH, 12-WEEK EUROPEAN Treatment with Esbriet (pirfenidone) significantly reduced cough by 34 percent in patients with idiopathic pulmonary fibrosis (IPF), along with cough severity, a new 12-week study shows. The study, “ Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis ” appeared in the European Respiratory journal.It marks the first time a clinical trial shows a significant IPF PATIENTS' LONG-TERM LUNG FUNCTION IMPROVES WITH OFEV IPF is a progressive lung disease with a median survival rate of only three years after diagnosis. The Phase 2 TOMORROW trial ( NCT00514683) evaluated Ofev ’s safety and effectiveness in two periods. Period 1 covered 52 weeks. The 428 patients in the randomized, placebo-controlled study received one of four doses of Ofev. MOST RELIABLE IPF THERAPIES ARE ESBRIET, OFEV, COMPARISON The first two approved therapies for idiopathic pulmonary fibrosis (IPF), Genentech’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib), are still the most reliable treatments among several approved and experimental therapies, according to a comparison study featured in the journal Pharmacometrics & Systems Pharmacology.. Since the U.S. FDA’s approval of these two IPF COPD AND BRONCHIECTASIS: SIMILARITIES AND DIFFERENCESSEE MORE ONLUNGDISEASENEWS.COM
LUNG INSTITUTE OPENS STEM CELL THERAPY CLINIC IN DALLAS A top provider of stem cell therapy research for lung conditions, the Lung Institute, recently announced its new location, close to the metro Dallas area in Texas.The Institute has also hired Dr. Sreedevi Marakatham as the new clinic’s medical director, helping to bring alternatives for patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary COMING SOON: SMARTWATCH THAT MONITORS SPO2 AND VITAL SIGNS Wearable devices have been trending in the tech market, boasting hi-tech features that allow real-time fitness and body response tracking and syncing with one’s smartphone. Biomedical companies, such as Aseptika Limited, specialize in developing and marketing an integrated suite of self-monitoring devices and services under their Activ8rlives brand, with a focus on respiratory conditions.LUNG DISEASE NEWS
Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. PULMONARY FIBROSIS SYMPTOMS: ACHING JOINTS AND MUSCLES Pulmonary fibrosis is a chronic lung disease where tissue in the lungs becomes scarred and thickens. This leads to common symptoms such as a persistent cough, shortness of breath, weight loss, fatigue, and digital clubbing. MORE: 6 Famous People Who Lost Their Battle With Pulmonary Fibrosis. Many pulmonary fibrosis patients also suffer from aching joints and muscles. 10 LUNG TRANSPLANT FACTS Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. 7 FAMOUS PEOPLE WHO LOST THEIR BATTLE WITH PULMONARY Sheila Matthews Allen Sheila Matthews Allen was a Hollywood actress famous for roles in the films Poseidon Adventure and Towering Inferno and TV shows like Lost in Space and The Waltons.Allen passed away in November 2013 after a prolonged battle with pulmonary fibrosis. 6 PULMONARY FIBROSIS COMPLICATIONS According to the Mayo Clinic, though no current cure for pulmonary fibrosis exists, medications and other treatment options can help improve a patient’s quality of life. As the disease evolves, several complications may arise. Here is a list of six possible pulmonary fibrosis complications: 1. RESPIRATORY INFECTION LINKED TO INCREASED RISK OF HEART ATTACK New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a heart attack, is 17 times higher in the seven days following a respiratory tract infection.. The study, “ Triggering of acute myocardial infarction by respiratory infection,” was published in the Internal Medicine Journal. COMING SOON: SMARTWATCH THAT MONITORS SPO2 AND VITAL SIGNS Wearable devices have been trending in the tech market, boasting hi-tech features that allow real-time fitness and body response tracking and syncing with one’s smartphone. Biomedical companies, such as Aseptika Limited, specialize in developing and marketing an integrated suite of self-monitoring devices and services under their Activ8rlives brand, with a focus on respiratory conditions. GALECTO'S IPF DRUG CANDIDATE TD139 SHOWS PROMISE IN Galecto Biotech has completed a Phase 1b/2a clinical trial that indicated its inhaled therapy candidate TD139 shows promise in treating idiopathic pulmonary fibrosis (IPF) patients.. TD139 is an inhibitor of galectin-3, a protein known to play a key role in fibrosis in several organs, including the lungs. Previous studies have shown that inhibiting galectin-3 reduced or even prevented fibrosis ADULTS BORN PREMATURE HAVE LUNG LIMITATIONS SIMILAR TO According to a recent study published in the Annals of the American Thoracic Society, adults born very or extremely preterm have respiratory limitations to exercise similar to patients with chronic obstructive pulmonary disease, similar to healthy elderly or casual smokers by the time they reach their early 20s.. The study, led by Andrew T. Lovering, a professor of human physiology at the PF PROGRESSION CAN BE SLOWED BY PRM, A TRADITIONAL CHINESE Pulmonary rehabilitation mixture (PRM), an herbal-based formula used for decades in Chinese traditional medicine, has therapeutic potential against pulmonary fibrosis (PF) progression by targeting several molecular factors known to be involved in fibrotic processes, concludes a new study.__
Skip to content
* Home
* News
* COPD
* Lung Cancer
* Asthma
* Cystic Fibrosis
* Pulmonary Hypertension * Idiopathic Pulmonary Fibrosis* Bronchiectasis
* About Lung Disease * Chronic Bronchitis* Emphysema
* Asthma
* COPD Overview
* COPD Symptoms
* COPD Diagnosis
* COPD Treatment
* Bronchiectasis OverviewSearch for:
*
February 28, 2018
RARE DISEASE DAY: HOW YOU CAN HELP RAISE AWARENESSSocial Clips
Rare Disease Day takes place on the last day of February. The worldwide event has gained a lot of ... Read more*
February 27, 2018
6 DOS AND DON’TS FOR LIVING WELL WITH A CHRONIC ILLNESSSocial Clips
In response to how to cope with a chronic illness, many reply with the following statement: “there is no ... Read more*
February 22, 2018
THE MANY BENEFITS OF SELF-CARE & FINDING BALANCESocial Clips
In a society that appears to glorify multitasking, after-hours meetings, excessive screen time and full schedules, it’s more important ... Read more*
February 21, 2018February 21, 2018 PROMETIC’S PBI-4050 REGULATES 2 RECEPTORS KEY TO FIBROSIS DEVELOPMENT, STUDY SHOWS Idiopathic Pulmonary Fibrosis,
News
PBI-4050, Prometic Life Sciences’ lead small molecule therapy candidate, targets a new antifibrotic pathway involving two receptors that play ... Read more*
February 21, 2018
THE INVISIBLE IMPACT OF TRAUMA ON PULMONARY FIBROSIS PATIENTSSocial Clips
With the exception of using supplemental oxygen, pulmonary fibrosis (PF) is an invisible disease for the most part. Like ... Read more*
February 20, 2018February 20, 2018 SYNTHETIC PROTEINS THAT MIMIC ENZYME HYAL2 MAY BE POTENTIAL THERAPEUTIC STRATEGY FOR PF, RESEARCHERS SAY Idiopathic Pulmonary Fibrosis,
News
Researchers found that an enzyme previously linked only to cell metabolism is capable of reaching the nucleus of lung ... Read more*
February 20, 2018
CONSIDERING LUNG TRANSPLANTATION: THE PROS & CONSSocial Clips
When the only “known” cure for idiopathic pulmonary fibrosis (IPF) is removing the diseased lungs and replacing them ... Read more*
February 19, 2018February 19, 2018 PHASE 2 TRIAL SHOWS KD025 HAS POTENTIAL TO PREVENT LUNG FUNCTIONDECLINE IN IPF
Idiopathic Pulmonary Fibrosis,
News
An investigative drug developed by Kadmon called KD025 was shown to be safe and effective to prevent lung function decline in ... Readmore
*
February 16, 2018February 16, 2018 SHORT-ACTING ASTHMA RELIEVERS LINKED TO FEMALE INFERTILITYAsthma , News
Women who use only short-acting asthma medications take longer to become pregnant than non-asthmatic women or women taking ... Read more*
February 15, 2018
WHY YOU SHOULD CONSIDER JOINING OUR ONLINE FORUMSocial Clips
The Pulmonary Fibrosis News forums launched a week ago! Many members have shared the PF forums with their ... Read more*
February 15, 2018February 15, 2018 NICE OPINION LIMITING ESBRIET TO UK PATIENTS WITH MODERATE TO SEVERE IPF DISAPPOINTS, PATIENTMPOWER SAYS Idiopathic Pulmonary Fibrosis,
News
The digital healthcare company patientMpower expressed disappointment at the opinion issued by an influential U.K. healthcare advisory group to limit ... Read more*
February 14, 2018February 14, 2018 FDA APPROVES VERTEX’S SYMDEKO TO TREAT CF PATIENTS 12 AND OLDERCystic Fibrosis
The U.S. Food and Drug Administration (FDA) has approved the third targeted therapy developed by Vertex Pharmaceuticals for patients ...Read more
*
*
*
*
*
*
*
*
*
*
*
*
* Previous
* Next
PULMONARY FIBROSIS
*
February 21, 2018February 21, 2018 PROMETIC’S PBI-4050 REGULATES 2 RECEPTORS KEY TO FIBROSIS DEVELOPMENT, STUDY SHOWS PBI-4050, Prometic Life Sciences’ lead small molecule therapy candidate, targets a new antifibrotic pathway involving two receptors that play opposite roles in fibrosis development, ... Read more*
February 20, 2018February 20, 2018 SYNTHETIC PROTEINS THAT MIMIC ENZYME HYAL2 MAY BE POTENTIAL THERAPEUTIC STRATEGY FOR PF, RESEARCHERS SAY Researchers found that an enzyme previously linked only to cell metabolism is capable of reaching the nucleus of lung fibroblasts and once there, halting ... Read more*
February 19, 2018February 19, 2018 PHASE 2 TRIAL SHOWS KD025 HAS POTENTIAL TO PREVENT LUNG FUNCTIONDECLINE IN IPF
An investigative drug developed by Kadmon called KD025 was shown to be safe and effective to prevent lung function decline in patients with idiopathic pulmonary ... Read moreASTHMA
*
February 16, 2018February 16, 2018 SHORT-ACTING ASTHMA RELIEVERS LINKED TO FEMALE INFERTILITY Women who use only short-acting asthma medications take longer to become pregnant than non-asthmatic women or women taking long-acting medications, a new international ... Read more*
January 25, 2018January 25, 2018 CDC STUDIES ASTHMA BURDEN ON U.S. ECONOMY — AND NUMBERS ARESTRIKING
Asthma costs the U.S. economy nearly $82 billion a year, say researchers at the Centers for Disease Control and Prevention (CDC). Using data ... Read more*
January 16, 2018January 16, 2018 FASENRA APPROVED IN EU FOR TREATMENT OF SEVERE EOSINOPHILIC ASTHMA The European Commission has approved Fasenra (benralizumab) as an add-on maintenance treatment in patients with severe eosinophilic asthma. The approval, announced by therapy developer AstraZeneca and its global research ... Read moreBRONCHIECTASIS
*
February 1, 2018February 1, 2018 FDA GIVES ARADIGM RECOMMENDATIONS FOR RESUBMITTING BRONCHIECTASISTHERAPY APPLICATION
The U.S. Food and Drug Administration has given Aradigm a list of suggestions for resubmitting an application for regulatory review of its bronchiectasis therapy Linhaliq. A ... Read more*
January 18, 2018January 18, 2018 FDA ADVISORY COMMITTEE DOES NOT RECOMMEND APPROVAL OF INHALANTLINHALIQ
The Antimicrobial Drugs Advisory Committee (ADAC) of the U.S. Food and Drug Administration (FDA) did not recommend approval of Aradigm’s Linhaliq for the treatment ... Read more*
December 4, 2017December 4, 2017 FDA ADVISORY GROUP SETS JAN. 11 REVIEW DATE FOR LINHALIQ, POTENTIAL NON-CF BRONCHIECTASIS THERAPY A committee of the U.S. Food and Drug Administration (FDA) will meet next month to review an application for Linhaliq to be approved for the treatment ... Read moreBRONCHIOLITIS
*
March 7, 2017March 7, 2017 TREATMENT SEEN TO LESSEN FIBROTIC SCARRING THAT CAUSES LUNGTRANSPLANTS TO FAIL
Treatment may be able prevent the progressive accumulation of scar tissue (fibrosis) in newly transplanted lungs that eventually cause those organs to fail, researchers at the University ... Read more*
January 18, 2017January 18, 2017 EUROPEAN RESEARCHERS AWARDED €29M GRANT TO ASSESS RSV LUNGINFECTIONS
Specialists in respiratory syncytial virus (RSV) from the RSV Consortium in Europe received a grant worth 29 million euro (equal to about $30.8 million American) ... Read more*
April 5, 2016April 5, 2016 IN INFANTS WITH BRONCHIOLITIS, STUDY POINTS TO NEED FOR RE-EVALUATION OF CLINICAL CARE, DIAGNOSTIC TOOLS In a new study, researchers at The Hospital for Sick Children (SickKids) in Toronto, Canada, analyzed the suitability of pulse oximetry as a decision-making ... Read moreCHRONIC BRONCHITIS
*
May 17, 2017May 17, 2017 RESPIRATORY INFECTIONS LINKED TO INCREASED RISK OF HEART ATTACK New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a ... Read more*
February 17, 2017February 17, 2017 EUROPEAN ENVIRONMENTAL FEDERATION HAILS EU AIR-STANDARDS COMPLIANCEMOVE
The non-profit European Environmental Bureau (EEB) is hailing a European Commission move toward legal action against France, Germany, Italy, Spain and the United Kingdom for ... Read more*
November 8, 2016November 8, 2016 CAN CERTAIN ODORS WORSEN AIRWAY DISEASES? RESEARCHERS THINK SO Olfactory receptors, a group of proteins that are activated by certain odors in the nose, can also be found in bronchi cells, wherethey ... Read more
Search for:
NEVER MISS ANOTHER LUNG DISEASE UPDATE. * indicates requiredEmail Address *
First Name *
Last Name
YOU MAY ALSO LIKE….. IPF WORLD WEEK 2017: LISTENING FOR THE SOUNDS OF IPF MAY LEAD TOEARLIER DIAGNOSIS
September 21, 2017
YOUNG GIRL AWARDED PRIZE FOR PULMONARY FIBROSIS AWARENESSJuly 17, 2017
STUDY SUPPORTS THE DEVELOPMENT OF ENVISIA GENOMIC CLASSIFIER FOR IPFDIAGNOSIS
July 6, 2017
Lung Disease NewsFollow OnCOPD
*
February 7, 2018February 7, 2018 REMOTE MONITORING COULD HELP COPD PATIENTS, BUT MORE STUDIES NEEDED, RESEARCHERS CONCLUDE Devices that remotely monitor COPD patients’ conditions could help improve their outcomes, a study suggests. A Cedars-Sinai Medical Center team said there were signs in ... Read more*
January 29, 2018January 29, 2018 COPD CARE AT HOME RATHER THAN HOSPITAL BOOSTS PATIENT OUTCOMES, CANADIAN STUDY FINDS Moving chronic obstructive pulmonary disease (COPD) patients from hospitals to their homes could improve the sustainability of Canada’s health system while improving individual outcomes, says ...Read more
*
November 27, 2017November 27, 2017 NEW YORK’S MONTEFIORE EINSTEIN CENTER LAUNCHES LUNG TRANSPLANTPROGRAM
New York City’s Montefiore Einstein Center for Heart & Vascular Care has received interim approval from the United Network for Organ Sharing (UNOS) to launch its ... Read more*
September 15, 2017September 15, 2017 IDENTIFICATION OF REGENERATIVE AND SCAR-FORMING CELLS MAY LEAD TO NEW LUNG THERAPIES, STUDY REPORTS Researchers have identified two types of lung cells, one with regenerative features and the other with scar-forming characteristics, according to a study published in ... Read more*
September 11, 2017September 11, 2017 STUDY LINKS FUNGUS ANTIBODIES WITH DEVELOPMENT OF BRONCHIECTASIS INCOPD PATIENTS
Researchers have linked the presence of antibodies against the Aspergillus fumigatus (A fum) fungus with the development of bronchiectasis in people with COPD. The study, “Sensitization ...Read more
*
August 29, 2017August 29, 2017 THREE SHARE BRITISH LUNG FOUNDATION GRANT FOR LUNG DISEASE RESEARCH Toby Maher, MD, a professor at Imperial College London and based at the National Heart and Lung Institute, is one of three researchers who were awarded the ... Read moreCYSTIC FIBROSIS
*
February 14, 2018February 14, 2018 FDA APPROVES VERTEX’S SYMDEKO TO TREAT CF PATIENTS 12 AND OLDER The U.S. Food and Drug Administration (FDA) has approved the third targeted therapy developed by Vertex Pharmaceuticals for patients with cystic fibrosis (CF). Symdeko can ... Read more*
February 5, 2018February 5, 2018 VERTEX SELECTS VX-659 AND VX-445 FOR TWO CF TRIPLE COMBO REGIMENS Vertex Pharmaceuticals has selected two of its next-generation correctors, VX-659 and VX-445, for Phase 3 trial development as part of two triple combination regimens for ... Read more*
January 12, 2018January 12, 2018 EUROPEAN UNION APPROVES ORKAMBI USE FOR CHILDREN 6-11 YEARS OLD The European Commission has granted Vertex Pharmaceuticals an extension of the marketing authorization for Orkambi (lumacaftor/ivacaftor) to include children 6-11 years ... Read more*
January 9, 2018January 9, 2018 PROTEOSTASIS’ PLANNED TRIAL OF TRIPLE COMBO CF THERAPY SUPPORTED BY ADVOCACY GROUPS IN US, EUROPE The drug development arms of two leading cystic fibrosis (CF) organizations, one in the U.S. and one in Europe, have endorsed Proteostasis Therapeutics’ coming ... Read more*
January 3, 2018January 3, 2018 TOP 10 LUNG DISEASE STORIES OF 2017 During 2017 Lung Disease News provided you with daily coverage on research, clinical trials and other developments in lung diseases. Here are our top ... Read more*
December 12, 2017December 12, 2017 KALYDECO SEEN AS SAFE IN TREATING CF IN YOUNG CHILDREN, AGES 1 TO 2,STUDY DATA SHOW
Kalydeco (ivacaftor) was shown to be safe and well-tolerated in 1- and 2-year-old children with cystic fibrosis (CF), based on data froma ... Read more
EMPHYSEMA
*
January 18, 2017January 18, 2017 EUROPEAN RESEARCHERS AWARDED €29M GRANT TO ASSESS RSV LUNGINFECTIONS
Specialists in respiratory syncytial virus (RSV) from the RSV Consortium in Europe received a grant worth 29 million euro (equal to about $30.8 million American) ... Read more*
November 8, 2016November 8, 2016 CAN CERTAIN ODORS WORSEN AIRWAY DISEASES? RESEARCHERS THINK SO Olfactory receptors, a group of proteins that are activated by certain odors in the nose, can also be found in bronchi cells, wherethey ... Read more
*
September 15, 2016September 15, 2016 HOMOGENEOUS EMPHYSEMA PATIENTS COULD BENEFIT FROM ZEPHYR ENDOBRONCHIAL VALVE, STUDY SHOWS Pulmonx recently announced positive results from the IMPACT (NCT02025205) study assessing the company’s proprietary Zephyr endobronchial valve (EBV), showing that patients with homogeneous emphysema benefit ... Read more*
September 8, 2016September 8, 2016 NEW LUNG ANALYSIS PLATFORM RAPIDLY IDENTIFIES PATIENTS ELIGIBLE FOR ENDOBRONCHIAL VALVE TREATMENT Pulmonx recently announced that its StratX Lung Analysis Platform is commercially available in countries requiring CE mark (Conformité Européne, a mark that proves a ... Read more*
August 17, 2016August 17, 2016 PULMONARY PROBLEMS CAN PLAGUE CHILDHOOD CANCER SURVIVORS THROUGHADULT LIFE
Pulmonary complications can mount in childhood survivors of cancer for as long as 25 years after initial diagnosis, and have a substantial impact on their ... Read more*
July 12, 2016July 12, 2016 RESEARCHERS SAY LUNG-TARGETED GENE THERAPY MAY IMPROVE TREATMENTS FORINHERITED DISEASES
A team of researchers from the Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center (BMC) developed a new treatment approach ... Read more IDIOPATHIC PULMONARY FIBROSIS*
February 21, 2018February 21, 2018 PROMETIC’S PBI-4050 REGULATES 2 RECEPTORS KEY TO FIBROSIS DEVELOPMENT, STUDY SHOWS PBI-4050, Prometic Life Sciences’ lead small molecule therapy candidate, targets a new antifibrotic pathway involving two receptors that play opposite roles in fibrosis development, ... Read more*
February 20, 2018February 20, 2018 SYNTHETIC PROTEINS THAT MIMIC ENZYME HYAL2 MAY BE POTENTIAL THERAPEUTIC STRATEGY FOR PF, RESEARCHERS SAY Researchers found that an enzyme previously linked only to cell metabolism is capable of reaching the nucleus of lung fibroblasts and once there, halting ... Read more*
February 19, 2018February 19, 2018 PHASE 2 TRIAL SHOWS KD025 HAS POTENTIAL TO PREVENT LUNG FUNCTIONDECLINE IN IPF
An investigative drug developed by Kadmon called KD025 was shown to be safe and effective to prevent lung function decline in patients with idiopathic pulmonary ... Read more*
February 15, 2018February 15, 2018 NICE OPINION LIMITING ESBRIET TO UK PATIENTS WITH MODERATE TO SEVERE IPF DISAPPOINTS, PATIENTMPOWER SAYS The digital healthcare company patientMpower expressed disappointment at the opinion issued by an influential U.K. healthcare advisory group to limit the use of Esbriet ... Read more*
February 13, 2018February 13, 2018 PULMONARY FIBROSIS FOUNDATION CREATES WEBSITE TO HELP PATIENTS FINDCLINICAL TRIALS
The Pulmonary Fibrosis Foundation has created an online Clinical Trial Finder to help pulmonary fibrosis patients search for trials to enroll in. Foundation officials said the site ... Read more*
February 12, 2018February 12, 2018 VANDERBILT TEAM TO TEST ANTIVIRAL THERAPY FOR PULMONARY FIBROSIS A Vanderbilt University team will study whether adding a commonly used antiviral medicine to standard treatments for idiopathic pulmonary fibrosis can help stop or reverse ... Read moreLUNG CANCER
*
February 6, 2018February 6, 2018 SINGLE BLOOD TEST SCREENS FOR 8 CANCER TYPES, HELPS SPOT TUMORLOCATION
A new blood test can screen for eight cancer types and help spot the tumor location, a recent study from Johns Hopkins Kimmel Cancer ...Read more
*
January 10, 2018January 10, 2018 INSURANCE COVERAGE AFFECTS TREATMENT GIVEN SMALL-CELL LUNG CANCER PATIENTS IN US, STUDY SHOWS Insurance status for people in the U.S. with non-metastatic small-cell lung cancer (SCLC) can determine both the type of treatment they are given and ... Read more*
January 5, 2018January 5, 2018 US CONTINUES ITS DECADES-LONG DROP IN CANCER MORTALITY RATES Cancer mortality rates in the United States have continued to steadily decline, with 2.4 million fewer cancer-related deaths reported in 2015 than in 1991, when ... Read more*
January 3, 2018January 3, 2018 TOP 10 LUNG DISEASE STORIES OF 2017 During 2017 Lung Disease News provided you with daily coverage on research, clinical trials and other developments in lung diseases. Here are our top ... Read more*
December 20, 2017December 20, 2017 AGGRESSIVE TREATMENT OF IPF PATIENTS WITH LUNG CANCER RARELY BESTOPTION, EXPERTS SAY
A group of clinician-reseachers with expertise in lung diseases suggest in a commentary that people with both idiopathic pulmonary fibrosis (IPF) and lung cancer are best ... Read more*
December 18, 2017December 18, 2017 GENENTECH’S NEW COMBO THERAPY IMPROVES PROGRESSION-FREE SURVIVAL IN ADVANCED NON-SMALL CELL LUNG CANCER Progression-free survival (PFS) was improved in patients with advanced non-squamous non-small cell lung cancer (NSCLC) using a combination of Avastin (bevacizumab), Tecentriq (atezolizumab), and... Read more
PNEUMONIA
*
October 12, 2017October 13, 2017 VIBATIV DISPLAYS MORE PUNCH AGAINST BACTERIA THAN OTHER ANTIBIOTICS,STUDIES SHOW
Vibativ (telavancin) displays more punch against the Staphylococcus aureus bacteria that is involved in lung diseases than other antibiotics it has been tested against, according to presentations ...Read more
*
August 18, 2017August 18, 2017 VACCINATION AGAINST LUNG PATHOGENS VITAL FOR PEOPLE WITH LUNG DISEASE, AMERICAN LUNG ASSOCIATION REMINDS August is National Immunization Awareness Month, and the American Lung Association is reminding adults with serious lung diseases that the Centers for Disease Control ... Read more*
August 8, 2017August 8, 2017 ARIDIS IS ENROLLING PATIENTS IN PIVOTAL TRIAL OF ITS ANTIBIOTIC-RESISTANT PNEUMONIA THERAPY AERUCIN Aridis Pharmaceuticals has begun enrolling patients in what it says will be a pivotal clinical trial of its antibiotic-resistant pneumonia therapy Aerucin. The trial will cover ... Read more*
May 17, 2017May 17, 2017 RESPIRATORY INFECTIONS LINKED TO INCREASED RISK OF HEART ATTACK New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a ... Read more*
February 14, 2017February 14, 2017 ANTIBIOTICS MAY MAKE NEWBORNS MORE SUSCEPTIBLE TO PNEUMONIA,RESEARCHERS SAY
Widespread use of antibiotics in newborns may interfere with gut bacteria, increasing the risk of the infants developing pneumonia, according to a study. The ... Read more*
February 2, 2017February 1, 2017 BU MEDICAL SCHOOL RESEARCHER AWARDED $5.9M TO STUDY BIOLOGY OFPNEUMONIA
A professor at Boston University School of Medicine (BUSM) has been awarded a $5.9 million Outstanding Investigator grant from the National Institutes of Health ... Read more PULMONARY HYPERTENSION*
January 19, 2018January 19, 2018 EIGER BIOPHARMACEUTICALS DISCONTINUES DEVELOPMENT OF UBENIMEX IN PAH AFTER DISAPPOINTING RESULTS Eiger BioPharmaceuticals will discontinue the development of ubenimex as a therapy for pulmonary arterial hypertension (PAH) due to disappointing results in the Phase 2 LIBERTY ... Read more*
January 11, 2018January 11, 2018 BELLEROPHON ENROLLS FIRST PATIENT IN STUDY OF INOPULSE TO TREAT PH LINKED TO INTERSTITIAL LUNG DISEASE A Phase 2b clinical study evaluating INOpulse as a treatment for pulmonary hypertension (PH) associated with interstitial lung disease (PH-ILD) enrolled the first patient, ... Read more*
November 15, 2017November 15, 2017 CANADIAN ASSOCIATION CONDUCTING PURPLE CHALLENGE CAMPAIGN DURING PHAWARENESS MONTH
The Pulmonary Hypertension Association of Canada is conducting a Life in Purple Challenge this month as part of its efforts to mark November as Pulmonary Hypertension Awareness ... Read more*
September 5, 2017September 5, 2017 STEADYMED’S NDA FOR TREVYENT TO TREAT PAH REFUSED BY FDA; MOREINFORMATION NEEDED
The U.S. Food and Drug Administration rejected SteadyMed’s new drug application (NDA) for Trevyent (treprostinil), a treatment for pulmonary arterial hypertension (PAH). According to ... Read more*
July 25, 2017July 25, 2017 ZAPPRX IMPLEMENTS SPECIALTY MEDICATION PRESCRIBING PLATFORM AT 2 PULMONARY MEDICAL CENTERS Harbor-UCLA Medical Center in Torrance, California, and Phoenix-based Arizona Pulmonary Specialists — the largest U.S. private practice treating pulmonary hypertension — now offer a digital platform designed ... Read more*
July 18, 2017July 18, 2017 MOUNT SINAI, THERAGENE COLLABORATE TO DEVELOP NEW GENE THERAPY FOR PULMONARY HYPERTENSION Researchers from New York’s Mount Sinai have partnered with Theragene Pharmaceuticals to further develop a new airway-delivered gene therapy for pulmonary hypertension (PH). After showing promising results in animal studies, this ... Read moreSCLERODERMA
*
January 11, 2017January 11, 2017 MOLECULE SEEN TO BE MARKER OF SCLEROSIS-LINKED LUNG DISEASE, ITSSEVERITY
In the majority of patients with systemic sclerosis (SSc), interstitial lung disease (ILD) is the leading cause of death. New research shows that plasma ... Read more*
May 26, 2016May 26, 2016 PROMISING SCLERODERMA CLINICAL TRIAL MAY IMPROVE HAND DYSFUNCTION Cytori Therapeutics provided a recent update on results from clinical trials assessing the use of Cytori Cell Therapy (ECCS-50) in the treatment of scleroderma-related hand dysfunction. The ... Readmore
*
May 3, 2016May 3, 2016 CYTORI UPDATES PHASE 3 SCLERODERMA STAR TRIAL, ENROLLS 60TH PATIENT Cell therapy company Cytori Therapeutics announced that its Phase 3 STAR clinical trial has enrolled and treated its 60th patient, reaching 75 percent of the target ... Read more*
May 2, 2016May 2, 2016 CUMBERLAND PHARMACEUTICALS TO BEGIN DEVELOPMENT OF SCLERODERMA DRUGVASCULAN
Cumberland Pharmaceuticals recently added Vasculan to its clinical portfolio. The company has began the clinical development of Vasculan (ifetroban) oral capsule for the treatment ... Read more*
April 29, 2016April 29, 2016 FIBROCELL’S GENE THERAPY FOR LOCALIZED SCLERODERMA DESIGNATED ANORPHAN DRUG BY FDA
Fibrocell Science, Inc., recently announced that the U.S. Food and Drug Administration (FDA) has designated FCX-013 an orphan drug for the potential treatment of localized ... Read more*
April 20, 2016April 20, 2016 SMALL PROTEIN M10 COULD HELP PREVENT LUNG FIBROSIS, ACCORDING TOANIMAL STUDY
A new study from researchers in South Carolina report that a small protein called M10 peptide might prevent fibrosis (scarring) in people with systemic sclerosis ... Read moreLUNG DISEASE NEWS
BioNews Services, LLC1601 Market St.
Suite 20A105
Philadelphia, PA 19103 Email: info@bionewsservices.comPhone: 214-379-7441
RECENT POSTS
*
RARE DISEASE DAY: HOW YOU CAN HELP RAISE AWARENESSFebruary 28, 2018
*
6 DOS AND DON’TS FOR LIVING WELL WITH A CHRONIC ILLNESSFebruary 27, 2018
*
THE MANY BENEFITS OF SELF-CARE & FINDING BALANCEFebruary 22, 2018
*
PROMETIC’S PBI-4050 REGULATES 2 RECEPTORS KEY TO FIBROSIS DEVELOPMENT, STUDY SHOWSFebruary 21, 2018
* About LD News
* Contact Us
* Privacy Policy
* Terms of Service
* Advertising
DISCLAIMER:
Lung Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Copyright © 2013-2020 All rights reserved. We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead moreDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0